Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2007; 132(30): 1577-1580
DOI: 10.1055/s-2007-984938
DOI: 10.1055/s-2007-984938
Aktuelle Diagnostik & Therapie | Review article
Pädiatrie, Diabetologie, Molekularbiologie, Endokrinologie© Georg Thieme Verlag KG Stuttgart · New York
Neonataler Diabetes - molekulargenetische Diagnostik wegweisend
Neonatal diabetes - molecular diagnosis is evidentFurther Information
Publication History
eingereicht: 12.3.2007
akzeptiert: 28.6.2007
Publication Date:
13 July 2007 (online)

Schlüsselwörter
neonataler Diabetes mellitus - Kir6.2 - Uniparentale paternale
Isodisomie
Key words
neonatal diabetes mellitus - Kir6.2 Gene - paternal uniparental
isodisomy
Literatur
- 1
Codner E, Flanagan S, Ellard S. et al .
High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in
early-onset diabetes caused by a novel R201L Kir6.2 Mutation.
Diabetes Care.
2005;
28
758-759
MissingFormLabel
- 2
Flanagan S, Edghill E, Gloyn A. et al .
Mutations in KCNJ 11, which encodes Kir 6.2, are common cause of diabetes diagnosed
in the first 6 months of life, with the phenotype defined by the genotype.
Diabetologia.
2006;
49
1190-1197
MissingFormLabel
- 3
Gardner R, Mackay D, Mungall A. et al .
An imprinted locus associated with transient neonatal diabetes mellitus.
Hum Mol Genet.
2000;
9
589-596
MissingFormLabel
- 4
Gloyn A, Pearson E, Antcliff J. et al .
Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit
Kir6.2 and permanent neonatal diabetes.
N Engl J Med.
2004;
350
1838-1849
MissingFormLabel
- 5
Gloyn A, Reimann F, Girard C. et al .
Relapsing diabetes can result from moderately activating mutations in KCNJ11.
Hum Mol Genet.
2005;
14
925-934
MissingFormLabel
- 6
Hattersley A, Ashcroft F.
Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new
scientific insights, and new therapy.
Diabetes.
2005;
54
2503-2513
MissingFormLabel
- 7
Iafusco D, Stazi M A, Cotichini R. et al .
Permanent diabetes mellitus in the first year of life.
Diabetologia.
2002;
45
798-804
MissingFormLabel
- 8
Inagaki N, Gonoi T J.
Reconstitution of IK-ATP: an inward rectifier subunit plus the sulphonylurea receptor.
Science.
1995;
270
1166-1170
MissingFormLabel
- 9
Mackay D, Coupe A, Shield J, Storr J, Temple I, Robinson D.
Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal
diabetes mellitus.
Hum Genet.
2002;
110
139-144
MissingFormLabel
- 10
Massa O, Iafusco D, D’Amato E. et al .
KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.
Hum Mutat.
2005;
25
22-27
MissingFormLabel
- 11
Polak M, Shield J.
Neonatal and very-early-onset diabetes mellitus.
Semin Neonatol.
2004;
9
59-65
MissingFormLabel
- 12
Sagen J, Raeder H, Hathout E. et al .
Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics
and initial response to sulfonylurea therapy.
Diabetes.
2004;
53
2713-2718
MissingFormLabel
- 13
Slingerland A.
Monogenic diabetes in children and young adults: Challenges for researcher, clinician
and patient.
Rev Endocr Metab Disord.
2006;
7
171-185
MissingFormLabel
- 14
Temple I, Gardner R, Mackay D. et al .
Transient neonatal diabetes: widening the understanding of the etiopathogenesis of
diabetes.
Diabetes.
2000;
49
1359-1366
MissingFormLabel
- 15
Von Mühlendahl K, Herkenhoff H.
Long term course of neonatal diabetes.
N Engl J Med.
1995;
333
704-708
MissingFormLabel
- 16
Zung A, Glaser B, Nimri R. et al .
Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating
mutation in Kir6.2.
J Clin Endocrinol Metab.
2004;
89
5504-5507
MissingFormLabel
Dr. med. Thomas Kapellen
Universitätsklinik und Poliklinik für Kinder und Jugendliche, Diabetesambulanz
Oststraße 21-25
04317 Leipzig
Phone: 0341/9726168
Fax: 0341/9726169
Email: Kapt@medizin.uni-leipzig.de